HEIDI REZENDES: Open Payments
NPI 1447503081 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,295 in 71 payments from 11 companies in 2025. Trend: 2023 $1,792 · 2024 $2,292 · 2025 $1,295
Food & beverage: $1,295
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $810 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $112 |
| Phathom Pharmaceuticals, Inc. | 6 | $105 |
| Lilly USA, LLC | 2 | $52 |
| Intercept Pharmaceuticals, Inc. | 2 | $50 |
| GENZYME CORPORATION | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Gilead Sciences, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: RINVOQ, SKYRIZI, ENTYVIO, VOQUEZNA, DUPIXENT, OMVOH, OCALIVA, IQIRVO.
Industry payments across MA — which companies pay providers there.
